← Leaderboards
Ami B Patel
University Of Utah
$1,159,632
Attributed
$1,159,632
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $289.9K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,159,632 · 1
By mechanism
K08$1,159,632 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Douglas Grossman$4,250,913
- Anne V Kirby$949,806
- Jared Wallace$140,184
- Yue Lu$2,078,051
- Sabrina Malone Jenkins$807,738
Others in their field
Other Rising Stars on “Clinical Trials Design”
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$30,895,527
- Suma Babu · Massachusetts General Hospital$30,895,527
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
Research focus
Clinical Trials DesignCohortClinical Trial ImplementationClinical TrialsAwardAffectBioinformaticsAcute Myelocytic LeukemiaBiologyAllogenicBone MarrowBone Marrow FailureCancer Drug ResistanceCancer TherapyCareerCareer DevelopmentAcute Myeloid Leukemia CellCbl GeneCell LineCellsChronic Myelomonocytic LeukemiaClinical InvestigationClinical Investigator AwardCombinatorial
Grant awards (4)
Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia$289,908
K08 · FY2025 · CA · contact PI
Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia$289,908
K08 · FY2024 · CA · contact PI
Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia$289,908
K08 · FY2023 · CA · contact PI
Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia$289,908
K08 · FY2022 · CA · contact PI